abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Income Growth
238.33%
Quarterly · Period ending:
HQL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported238.33%period ending
Latest reported238.33%period ending
HQL Quarterly Operating Income YoY % (-4.08% → 238.33%)
Year-over-year change
High-resolution chart · PNG
HQL operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 238.3325% | |
| 10,583.6028% | |
| -7,129.7048% | |
| 88.9322% | |
| 30.5514% | |
| 59.5585% | |
| 98.767% | |
| -185.8528% | |
| -341.7949% | |
| -64.4988% | |
| 4.521% | |
| 7,151.1362% | |
| 2,032.9287% | |
| 27.8923% | |
| 12.2766% | |
| -86,955.8182% | |
| -99,896.5741% | |
| -19.3804% | |
| 12.4204% | |
| 24.8638% | |
| 14.6855% | |
| -17.5174% | |
| -34.2354% | |
| -21.2907% | |
| -132.2351% | |
| 99.5822% | |
| 99.9142% | |
| 79.3271% | |
| 53.1249% | |
| -93.8776% | |
| -93.8776% | |
| 37.7778% | |
| 37.7778% | |
| -7.8767% | |
| -7.8767% | |
| -70.7602% | |
| -70.7602% | |
| -27.6119% | |
| -27.6119% | |
| 48.2625% | |
| 48.2625% | |
| 15.6352% | |
| 15.6352% | |
| -31.1966% | |
| -31.1966% | |
| 7.1429% | |
| 7.1429% | |
| -29.8969% | |
| -29.8969% | |
| -14.3791% | |
| -14.3791% | |
| -4.0816% | |
| -4.0816% |